Universal Technical Institute (UTI) has delivered a mixed Q2 2026 report, with total revenue of US$221.4 million and basic EPS of US$0.01, compared with trailing twelve month EPS of US$0.78 on US$869.0 million of revenue. The company’s quarterly revenue has moved from US$201.4 million in Q1 2025 to US$221.4 million in the latest quarter. Over the same period, basic EPS has ranged from US$0.41 in Q1 2025 to US$0.24 in Q1 2026 and US$0.01 in Q2 2026. As a result, investors may pay particular attention to how the margin picture is evolving relative to the headline growth profile.

See our full analysis for Universal Technical Institute.

With the latest numbers on the table, the next step is to see how they compare with widely followed narratives around UTI's growth, profitability, and risk profile, and where those narratives might need to be updated.

Margins Thin Despite US$42.7m TTM Net Income

• On a trailing twelve month basis, UTI earned US$42.7 million of net income on US$869.0 million of revenue, which works out to a 6.3% net margin compared with 7.1% a year earlier.
• Consensus narrative sees campus expansion and new programs as long term margin drivers. However, the recent margin slip from 7.1% to 6.3% means investors have to weigh that bullish view against the reality that near term profitability has been tighter while investments ramp up.
  • Revenue across the last twelve months sits at US$869.0 million, while net income of US$42.7 million is lower than the US$63.1 million figure cited in the consensus storyline. This points to some pressure versus the multi year profit growth pace of 55.1% a year.
  • Bulls point to digitization, new HVAC, aviation, and allied health programs as future supports for margins, but the actual trailing data shows earnings growth over the most recent year was negative compared with the prior five year trend. As a result, the margin improvement thesis still needs firmer support from reported numbers.

Bulls who focus on long term growth drivers may want to see how the full positive case lines up with these tighter margins and recent earnings trends before leaning too hard on the forecast story. 🐂 Universal Technical Institute Bull Case

Q2 Net Income Slides To US$0.4m

• Quarterly net income for Q2 2026 was US$0.4 million versus US$12.8 million in Q1 2026 and US$18.8 million in Q4 2025, even though quarterly revenue held around the US$221 million level across those periods.
• Critics highlight that aggressive campus expansion and system integration could weigh on returns, and the pattern of much lower recent quarterly net income relative to the stronger five year earnings growth record shows why bearish voices focus on execution risk rather than just the long run growth story.
  • Basic EPS dropped from US$0.41 in Q1 2025 to US$0.24 in Q1 2026 and then US$0.01 in Q2 2026, which sits uneasily next to the long run 55.1% annualized earnings growth figure often cited in bullish arguments.
  • With analysts expecting margins to narrow from 7.8% to 5.2% over the next few years, the latest quarterly net income of US$0.4 million gives bears concrete recent data to point to when questioning whether newer campuses and programs will earn back their cost of growth.

If you want to see how cautious investors frame these softer earnings against UTI's expansion plans and regulatory exposure, it is worth reading the detailed risk focused angle. 🐻 Universal Technical Institute Bear Case

Premium 37.9x P/E Versus 6.3% Margin

• UTI trades on a trailing P/E of 37.9x compared with 16.4x for the US Consumer Services industry and 26.7x for peers, while the trailing net margin is 6.3% and a DCF fair value of US$35.57 sits slightly below the current share price of US$35.49.
• Analysts' consensus view links the expansion strategy to future earnings growth of about 16.8% a year. Yet the combination of a richer 37.9x P/E, a 6.3% trailing margin that has eased from 7.1%, and an analyst price target capped at US$42.50 means the valuation already bakes in a fair amount of confidence that growth initiatives will translate into durable profits.
  • Revenue for the trailing twelve months of US$869.0 million and net income of US$42.7 million are solidly in the hundreds of millions range, but the recent year of negative earnings growth relative to the five year average means the premium multiple is being applied to earnings that have not followed a straight upward path.
  • With earnings forecast to grow faster than revenue at roughly 16.8% versus 8.3% a year, but margins expected by analysts to move from 7.8% to 5.2%, the numbers capture a tension between top line expansion and profitability compression that readers should factor into any view on whether the current valuation feels stretched or reasonable.

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Universal Technical Institute on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

Given this mix of caution and optimism around UTI, it may be helpful to review the numbers yourself and assess how the story aligns with your own expectations. To round out that process, check the 1 key reward and 1 important warning sign

See What Else Is Out There

UTI's shrinking margins, softer recent earnings and premium 37.9x P/E all point to a story where profitability and valuation are working against each other.

If those pressure points make you want a wider menu of ideas, compare this setup with companies in the 44 high quality undervalued stocks to see where price and fundamentals line up more comfortably.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.